Home Nano Research Article
Article Link
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript
Show Outline
Outline
Graphical Abstract
Abstract
Keywords
Electronic Supplementary Material
References
Show full outline
Hide outline
Research Article

Co-delivery of luteolin and TGF-β1 plasmids with ROS-responsive virus-inspired nanoparticles for microenvironment regulation and chemo-gene therapy of intervertebral disc degeneration

Yifan Ding1,§, Huan Wang1,§, Yunyun Wang3, Long Li1, Jiahui Ding2, Caiyan Yuan2, Tao Xu1, Haoran Xu1, Hui Xie4, Ning Zhu5,6, Xin Hu6,7, Huang Fang1(), Songwei Tan2()
Department of Orthopedic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
Department of Cardiology, the Fifth Hospital in Wuhan, Wuhan 430030, China
Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing 211800, China
State Key Laboratory of Materials-Oriented Chemical Engineering, Nanjing Tech University, Nanjing 211800, China
College of Materials Science and Engineering, Nanjing Tech University, Nanjing 211800, China

§ Yifan Ding and Huan Wang contributed equally to this work.

Show Author Information

Graphical Abstract

View original image Download original image
A reactive oxygen species (ROS)-responsive nanoplatform (LUT-pTGF-β1@PBC) was constructed for LUT-TGF-β1 plasmid combinatorial therapy of intervertebral disc degeneration (IDD).

Abstract

Intervertebral disc degeneration (IDD) is closely related to inflammation and imbalance of synthesis/catabolism of extracellular matrix (ECM) in intervertebral disc (IVD). Considering this, luteolin (LUT), a kind of natural flavonoid with good anti-inflammatory effect and TGF-β1 (a gene that promotes the regeneration of ECM) plasmid was co-loaded and co-delivered to nucleus pulposus cells (NPCs). Reactive oxygen species (ROS) responsive cationic copolymer, poly(β-amino ester)-poly(ε-caprolactone) (PBC), with high plasmid DNA (pDNA) compression affinity was synthesized. It can self-assemble into nano-sized polyplexes (pDNA@PBC) with virus-inspired structure and function through which it can transfect pDNA into NPCs with very high efficiency and negligible cytotoxicity. LUT was encapsulated in the hydrophobic core of pDNA@PBC. The co-delivery system, LUT-pTGF-β1@PBC, could enhance the cellular uptake of NPCs and manifest excellent sustained drug release in IVD. Real time quantitative polymerase chain reaction (RT-qPCR) and Western blot experiments reveal that the co-delivery system could inhibit inflammation in NPCs and restore the balance of anabolism and catabolism in vitro by activating TGF/SMAD3 and inhibiting NF-kB/p65. Moreover, LUT-pTGF-β1@PBC retards IDD in vivo as detected by radiological and histological methods with good biosafety in rats. LUT-pTGF-β1@PBC may be a promising option for the treatment of IDD.

Keywords

intervertebral disc degenerationpoly(β-amino ester)luteolinTGF-β1co-delivery

Electronic Supplementary Material

Download File(s)
12274_2022_4285_MOESM1_ESM.pdf (1.4 MB)

References

1

Andersson, G. B. J. Epidemiological features of chronic low-back pain. Lancet 1999, 354, 581–585.

Crossref Google Scholar
2

Luoma, K.; Riihimaki, H.; Luukkonen, R.; Raininko, R.; Viikari-Juntura, E.; Lamminen, A. Low back pain in relation to lumbar disc degeneration. Spine 2000, 25, 487–492.

Crossref Google Scholar
3

Clouet, J.; Vinatier, C.; Merceron, C.; Pot-Vaucel, M.; Hamel, O.; Weiss, P.; Grimandi, G.; Guicheux, J. The intervertebral disc: From pathophysiology to tissue engineering. Joint Bone Spine 2009, 76, 614–618.

Crossref Google Scholar
4

Molinos, M.; Almeida, C. R.; Caldeira, J.; Cunha, C.; Gonçalves, R. M.; Barbosa, M. A. Inflammation in intervertebral disc degeneration and regeneration. J. Roy. Soc. Interface 2015, 12, 20150429.

Crossref Google Scholar
5

Cunha, C.; Silva, A. J.; Pereira, P.; Vaz, R.; Gonçalves, R. M.; Barbosa, M. A. The inflammatory response in the regression of lumbar disc herniation. Arthritis Res. Ther. 2018, 20, 251.

Crossref Google Scholar
6

Wu, P. H.; Kim, H. S.; Jang, I. T. Intervertebral disc diseases PART 2: A review of the current diagnostic and treatment strategies for intervertebral disc disease. Int. J. Mol. Sci. 2020, 21, 2135.

Crossref Google Scholar
7

Frapin, L.; Clouet, J.; Delplace, V.; Fusellier, M.; Guicheux, J.; Le Visage, C. Lessons learned from intervertebral disc pathophysiology to guide rational design of sequential delivery systems for therapeutic biological factors. Adv. Drug Deliv. Rev. 2019, 149–150, 49–71.

Crossref Google Scholar
8

Novais, E. J.; Tran, V. A.; Johnston, S. N.; Darris, K. R.; Roupas, A. J.; Sessions, G. A.; Shapiro, I. M.; Diekman, B. O.; Risbud, M. V. Long-term treatment with senolytic drugs dasatinib and quercetin ameliorates age-dependent intervertebral disc degeneration in mice. Nat. Commun. 2021, 12, 5213.

Crossref Google Scholar
9

Nishida, K.; Kang, J. D.; Gilbertson, L. G.; Moon, S. H.; Suh, J. K.; Vogt, M. T.; Robbins, P. D.; Evans, C. H. Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: An in vivo study of adenovirus-mediated transfer of the human transforming growth factor β1 encoding gene. Spine 1999, 24, 2419–2425.

Crossref Google Scholar
10

Wang, S. K.; Xue, Y. L.; Cepko, C. L. Microglia modulation by TGF-β1 protects cones in mouse models of retinal degeneration. J. Clin. Invest. 2020, 130, 4360–4369.

Crossref Google Scholar
11

Abulimiti, A.; Lai, M. S. L.; Chuen-Chang, R. Applications of adeno-associated virus vector-mediated gene delivery for neurodegenerative diseases and psychiatric diseases: Progress, advances, and challenges. Mech. Ageing Dev. 2021, 199, 111549.

Crossref Google Scholar
12

Zheng, G.; Pan, Z. Y.; Zhan, Y.; Tang, Q.; Zheng, F. H.; Zhou, Y. F.; Wu, Y. S.; Zhou, Y. L.; Chen, D. H.; Chen, J. X. et al. TFEB protects nucleus pulposus cells against apoptosis and senescence via restoring autophagic flux. Osteoarthritis Cartilage 2019, 27, 347–357.

Crossref Google Scholar
13

Farhang, N.; Ginley-Hidinger, M.; Berrett, K. C.; Gertz, J.; Lawrence, B.; Bowles, R. D. Lentiviral CRISPR epigenome editing of inflammatory receptors as a gene therapy strategy for disc degeneration. Hum. Gene Ther. 2019, 30, 1161–1175.

Crossref Google Scholar
14
Servick, K. Gene Therapy Clinical Trial Halted as Cancer Risk Surfaces [Online]. https://www.science.org/news/2021/08/gene-therapy-clinical-trial-halted-cancer-risk-surfaces (accessed Aug 11, 2021).
15

Nguyen, G. N.; Everett, J. K.; Kafle, S.; Roche, A. M.; Raymond, H. E.; Leiby, J.; Wood, C.; Assenmacher, C. A.; Merricks, E. P.; Long, C. T. et al. A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells. Nat. Biotechnol. 2021, 39, 47–55.

Crossref Google Scholar
16

Wallach, C. J.; Kim, J. S.; Sobajima, S.; Lattermann, C.; Oxner, W. M.; McFadden, K.; Robbins, P. D.; Gilbertson, L. G.; Kang, J. D. Safety assessment of intradiscal gene transfer: A pilot study. Spine J. 2006, 6, 107–112.

Crossref Google Scholar
17

Sainz-Ramos, M.; Gallego, I.; Villate-Beitia, I.; Zarate, J.; Maldonado, I.; Puras, G.; Pedraz, J. L. How far are non-viral vectors to come of age and reach clinical translation in gene therapy? Int. J. Mol. Sci. 2021, 22, 7545.

Crossref Google Scholar
18

Uzieliene, I.; Kalvaityte, U.; Bernotiene, E.; Mobasheri, A. Non-viral gene therapy for osteoarthritis. Front. Bioeng. Biotechnol. 2020, 8, 618399.

Crossref Google Scholar
19

Mashel, T. V.; Tarakanchikova, Y. V.; Muslimov, A. R.; Zyuzin, M. V.; Timin, A. S.; Lepik, K. V.; Fehse, B. Overcoming the delivery problem for therapeutic genome editing: Current status and perspective of non-viral methods. Biomaterials 2020, 258, 120282.

Crossref Google Scholar
20

Feng, G. J.; Chen, H. Y.; Li, J. J.; Huang, Q.; Gupte, M. J.; Liu, H.; Song, Y. M.; Ge, Z. S. Gene therapy for nucleus pulposus regeneration by heme oxygenase-1 plasmid DNA carried by mixed polyplex micelles with thermo-responsive heterogeneous coronas. Biomaterials 2015, 52, 1–13.

Crossref Google Scholar
21

Feng, G. J.; Zhang, Z. P.; Dang, M.; Zhang, X. J.; Doleyres, Y.; Song, Y. M.; Chen, D.; Ma, P. X. Injectable nanofibrous spongy microspheres for NR4A1 plasmid DNA transfection to reverse fibrotic degeneration and support disc regeneration. Biomaterials 2017, 131, 86–97.

Crossref Google Scholar
22

Wu, H. Y.; Zhong, D.; Zhang, Z. J.; Li, Y. C.; Zhang, X.; Li, Y. K.; Zhang, Z. Z.; Xu, X. H.; Yang, J.; Gu, Z. W. Bioinspired artificial tobacco mosaic virus with combined oncolytic properties to completely destroy multidrug-resistant cancer. Adv. Mater. 2020, 32, 2005181.

Crossref Google Scholar
23

Zou, Y.; Zheng, M.; Yang, W. J.; Meng, F. H.; Miyata, K.; Kim, H. J.; Kataoka, K.; Zhong, Z. Y. Virus-mimicking chimaeric polymersomes boost targeted cancer siRNA therapy in vivo. Adv. Mater. 2017, 29, 1703285.

Crossref Google Scholar
24

Zhuang, R.; Chen, M. Q.; Zhou, Y. H.; Cheng, W. J.; Zhang, T. H.; Ni, Y. F.; Guo, C. H.; Tu, J. S.; Jiang, L. Virus-mimicking liposomal system based on dendritic lipopeptides for efficient prevention ischemia/reperfusion injury in the mouse liver. ACS Macro Lett. 2021, 10, 215–222.

Crossref Google Scholar
25

Cordeiro, R. A.; Serra, A.; Coelho, J. F. J.; Faneca, H. Poly(β-amino ester)-based gene delivery systems: From discovery to therapeutic applications. J. Control. Release 2019, 310, 155–187.

Crossref Google Scholar
26

Bus, T.; Traeger, A.; Schubert, U. S. The great escape: How cationic polyplexes overcome the endosomal barrier. J. Mater. Chem. B 2018, 6, 6904–6918.

Crossref Google Scholar
27

Somiya, M.; Liu, Q. S.; Kuroda, S. Current progress of virus-mimicking nanocarriers for drug delivery. Nanotheranostics 2017, 1, 415–429.

Crossref Google Scholar
28

Chen, S.; Liu, S.; Ma, K.; Zhao, L.; Lin, H.; Shao, Z. TGF-β signaling in intervertebral disc health and disease. Osteoarthritis Cartilage 2019, 27, 1109–1117.

Crossref Google Scholar
29

Tran, C. M.; Shapiro, I. M.; Risbud, M. V. Molecular regulation of CCN2 in the intervertebral disc: Lessons learned from other connective tissues. Matrix Biol. 2013, 32, 298–306.

Crossref Google Scholar
30

Zhu, L. G.; Yu, C. S.; Zhang, X. F.; Yu, Z. B.; Zhan, F. Y.; Yu, X.; Wang, S. R.; He, F.; Han, Y. S.; Zhao, H. The treatment of intervertebral disc degeneration using traditional Chinese medicine. J. Ethnopharmacol. 2020, 263, 113117.

Crossref Google Scholar
31

Wuertz, K.; Quero, L.; Sekiguchi, M.; Klawitter, M.; Nerlich, A.; Konno, S. I.; Kikuchi, S. I.; Boos, N. The red wine polyphenol resveratrol shows promising potential for the treatment of nucleus pulposus-mediated pain in vitro and in vivo. Spine 2011, 36, E1373–E1384.

Crossref Google Scholar
32

Klawitter, M.; Quero, L.; Klasen, J.; Liebscher, T.; Nerlich, A.; Boos, N.; Wuertz, K. Triptolide exhibits anti-inflammatory, anti-catabolic as well as anabolic effects and suppresses TLR expression and MAPK activity in IL-1β treated human intervertebral disc cells. Eur. Spine J. 2012, 21, 850–859.

Crossref Google Scholar
33

Wang, H.; Ding, Y.; Zhang, W.; Wei, K.; Pei, Y.; Zou, C.; Zhang, C.; Ding, J.; Fang, H.; Tan, S. Oxymatrine liposomes for intervertebral disc treatment: Formulation, in vitro and vivo assessments. Drug Des. Devel. Ther. 2020, 14, 921–931.

Crossref Google Scholar
34

Wei, K.; Dai, J.; Wang, Z. G.; Pei, Y. P.; Chen, Y.; Ding, Y. F.; Ding, Q.; Ahati, P.; Zhou, X. Z.; Wang, H. et al. Oxymatrine suppresses IL-1β-induced degradation of the nucleus pulposus cell and extracellular matrix through the TLR4/NF-κB signaling pathway. Exp. Biol. Med. 2020, 245, 532–541.

Crossref Google Scholar
35

Aziz, N.; Kim, M. Y.; Cho, J. Y. Anti-inflammatory effects of luteolin: A review of in vitro, in vivo, and in silico studies. J. Ethnopharmacol. 2018, 225, 342–358.

Crossref Google Scholar
36

Lin, J. L.; Chen, J. X.; Zhang, Z. J.; Xu, T. Z.; Shao, Z. X.; Wang, X. B.; Ding, Y. Z.; Tian, N. F.; Jin, H. M.; Sheng, S. R. et al. Luteoloside inhibits IL-1β-induced apoptosis and catabolism in nucleus pulposus cells and ameliorates intervertebral disk degeneration. Front. Pharmacol. 2019, 10, 868.

Crossref Google Scholar
37

Labet, M.; Thielemans, W. Synthesis of polycaprolactone: A review. Chem. Soc. Rev. 2009, 38, 3484–3504.

Crossref Google Scholar
38

Tao, W. H.; He, Z. G. ROS-responsive drug delivery systems for biomedical applications. Asian J. Pharm. Sci. 2018, 13, 101–112.

Crossref Google Scholar
39

Raza, A.; Hayat, U.; Rasheed, T.; Bilal, M.; Iqbal, H. M. N. Redox-responsive nano-carriers as tumor-targeted drug delivery systems. Eur. J. Med. Chem. 2018, 157, 705–715.

Crossref Google Scholar
40

Gao, X. Q.; Jin, Z.; Tan, X. Y.; Zhang, C.; Zou, C. M.; Zhang, W.; Ding, J. H.; Das, B. C.; Severinov, K.; Hitzeroth, I. I. et al. Hyperbranched poly(β-amino ester) based polyplex nanopaticles for delivery of CRISPR/Cas9 system and treatment of HPV infection associated cervical cancer. J. Control. Release 2020, 321, 654–668.

Crossref Google Scholar
41

Liu, Y. H.; Huang, W. J.; Zhu, N.; Guo, K. Direct synthesis of thiol-terminated poly(ε-caprolactone): A study on polymerization kinetics, mechanism and rare earth phenolates’ structure−activity relationship. RSC Adv. 2017, 7, 37412–37418.

Crossref Google Scholar
42

Liu, Y. H.; Yin, F.; Hu, X.; Zhu, N.; Guo, K. Protecting-group-free synthesis of thiol-functionalized degradable polyesters. Polym. Chem. 2021, 12, 1749–1757.

Crossref Google Scholar
43

Issy, A. C.; Castania, V.; Castania, M.; Salmon, C. E. G.; Nogueira-Barbosa, M. H.; Bel, E.; Defino, H. L. A. Experimental model of intervertebral disc degeneration by needle puncture in Wistar rats. Braz. J. Med. Biol. Res. 2013, 46, 235–244.

Crossref Google Scholar
44

Qian, J. L.; Ge, J.; Yan, Q.; Wu, C. H.; Yang, H. L.; Zou, J. Selection of the optimal puncture needle for induction of a rat intervertebral disc degeneration model. Pain Physician 2019, 22, 353–360.

Crossref Google Scholar
45

Pfirrmann, C. W. A.; Metzdorf, A.; Zanetti, M.; Hodler, J.; Boos, N. Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine 2001, 26, 1873–1878.

Crossref Google Scholar
46

Luo, C.; Sun, J.; Liu, D.; Sun, B. J.; Miao, L.; Musetti, S.; Li, J.; Han, X. P.; Du, Y. Q.; Li, L. et al. Self-assembled redox dual-responsive prodrug-nanosystem formed by single thioether-bridged paclitaxel-fatty acid conjugate for cancer chemotherapy. Nano Lett. 2016, 16, 5401–5408.

Crossref Google Scholar
47

Feng, C. C.; Yang, M. H.; Lan, M. H.; Liu, C.; Zhang, Y.; Huang, B.; Liu, H.; Zhou, Y. ROS: Crucial intermediators in the pathogenesis of intervertebral disc degeneration. Oxid. Med. Cell. Longev. 2017, 2017, 5601593.

Crossref Google Scholar
48

Peng, Y. Z.; Qing, X. C.; Shu, H. Y.; Tian, S.; Yang, W. B.; Chen, S. F.; Lin, H.; Lv, X.; Zhao, L.; Chen, X. et al. Proper animal experimental designs for preclinical research of biomaterials for intervertebral disc regeneration. Biomater. Transl. 2021, 2, 91–142.

Crossref Google Scholar
49

Xie, C. L.; Ma, H. W.; Shi, Y. F.; Li, J. L.; Wu, H. Q.; Wang, B.; Shao, Z. X.; Huang, C. G.; Chen, J. X.; Sun, L. J. et al. Cardamonin protects nucleus pulposus cells against IL-1β-induced inflammation and catabolism via Nrf2/NF-κB axis. Food Funct. 2021, 12, 2703–2714.

Crossref Google Scholar
50

Liu, J. W.; Jiang, T. M.; He, M. W.; Fang, D. P.; Shen, C.; Le, Y. G.; He, M. L.; Zhao, J. M.; Zheng, L. Andrographolide prevents human nucleus pulposus cells against degeneration by inhibiting the NF-κB pathway. J. Cell. Physiol. 2019, 234, 9631–9639.

Crossref Google Scholar
Nano Research
Volume 15 Issue 9,
September 2022
Pages 8214-8227
DOI: 10.1007/s12274-022-4285-7
Cite this article:
Ding Y, Wang H, Wang Y, et al. Co-delivery of luteolin and TGF-β1 plasmids with ROS-responsive virus-inspired nanoparticles for microenvironment regulation and chemo-gene therapy of intervertebral disc degeneration. Nano Research, 2022, 15(9): 8214-8227. https://doi.org/10.1007/s12274-022-4285-7
Topics:
Drug delivery
Metrics & Citations  
Article History
Copyright
Return